According to the latest status from September 2024, Canntab Therapeutics paid a total of 0 CAD per share in dividends within the last 12 months. With the current Canntab Therapeutics price of 0.01 CAD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.
| 58,000 % Dividend Yield | = |
|
A dividend is paid times per year. Last year, the payout months were and .
| Paydate | Dividend |
|---|---|
| 4/8/2016 | 0.01 |
Canntab Therapeutics has been increasing the dividend for 1 years.
Over the past 10 years, Canntab Therapeutics has increased it by an annual 0 %.
Over a five-year period, the distribution increased by 0%.
Analysts expect a Dividend Cut of -100% for the current fiscal year.
3 years
5 years
10 years
25 Years
Max
The yearly payout ratio for Canntab Therapeutics represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.
A lower payout ratio for Canntab Therapeutics could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.
Evaluate Canntab Therapeutics's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.
| Date | Canntab Therapeutics Payout ratio |
|---|---|
| 2022 | 251.97 % |
| 2021 | 251.97 % |
| 2020 | 251.97 % |
| 2019 | 251.97 % |
| 2018 | 251.97 % |
| 2017 | 251.97 % |
| 2016 | 251.97 % |
| 2015 | 251.97 % |
| 2014 | 251.97 % |
| 2013 | 251.97 % |
| 2012 | 251.97 % |
| 2011 | 251.97 % |
| 2010 | 251.97 % |
| Payout ratio | |
|---|---|
| 2010 | 251.97 % |
| 2011 | 251.97 % |
| 2012 | 251.97 % |
| 2013 | 251.97 % |
| 2014 | 251.97 % |
| 2015 | 251.97 % |
| 2016 | 251.97 % |
| 2017 | 251.97 % |
| 2018 | 251.97 % |
| 2019 | 251.97 % |
| 2020 | 251.97 % |
| 2021 | 251.97 % |
| 2022 | 251.97 % |
Canntab Therapeutics’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.
Examining Canntab Therapeutics's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.
Canntab Therapeutics's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.
Changes in Canntab Therapeutics’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.
Over the past 12 months, Canntab Therapeutics paid a dividend of 2.9 CAD . This corresponds to a dividend yield of about 58,000 %. For the coming 12 months, Canntab Therapeutics is expected to pay a dividend of 0 CAD.
The current dividend yield of Canntab Therapeutics is 58,000 %.
Canntab Therapeutics pays a quarterly dividend. This is distributed in the months of .
Canntab Therapeutics paid dividends every year for the past 0 years.
For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.
Canntab Therapeutics is assigned to the '-' sector.
To receive the latest dividend of Canntab Therapeutics from 4/30/2016 amounting to 0.015 CAD, you needed to have the stock in your portfolio before the ex-date on 3/8/2016.
The last dividend was paid out on 4/30/2016.
In the year 2023, Canntab Therapeutics distributed 0 CAD as dividends.
The dividends of Canntab Therapeutics are distributed in CAD.
Our stock analysis for Canntab Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Canntab Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.